CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	12 Months Ended
Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
OPERATING ACTIVITIES:
Net income	$ 53,848	$ 45,049	$ 75,574
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation	22,786	21,490	19,998
Amortization, including accretion of deferred financing costs	6,731	6,764	3,615
Deferred income taxes	2,552	(5,959)	(38,747)
Earnings of equity method investee	(2,038)	(1,636)	(1,233)
Loss (gain) on fixed assets	333	(1,796)	48
Share-based compensation expense	5,632	7,265	6,134
Tax provision (benefit) related to share-based compensation expense	(1,584)	(858)	(977)
Impairment of Goodwill	0	0	0
Change in fair value of earn-out contingent consideration	213	7,485
Intangible impairment charge	202
Changes in operating assets and liabilities, net of effect of business combination:
Accounts receivable, net	(3,575)	(15,156)	(18,694)
Inventories, net	(10,002)	(2,132)	4,519
Prepaid expenses and other assets	2,291	(10,177)	2,652
Accounts payable	11,054	10,492	10,980
Accrued expenses and other liabilities	(7,671)	18,077	1,408
Net cash provided by operating activities	80,772	78,908	65,277
INVESTING ACTIVITIES:
Capital expenditures	(29,027)	(32,170)	(24,476)
Proceeds from sale of fixed assets	111	77	652
Insurance proceeds for fixed assets	1,403	711
Business acquisition, net of cash acquired		(77,258)
Investment in venture capital fund	(437)
Net cash used for investing activities	(27,950)	(108,640)	(23,824)
FINANCING ACTIVITIES:
Acquisition of noncontrolling interest, including transaction costs		(1,848)
Revolving credit facility borrowings	27,500	95,000
Revolving credit facility payments	(52,500)	(41,000)	(33,000)
Proceeds from issuance of debt	415	2,748	16,223
Repayments of debt	(5,071)	(11,573)	(25,748)
Other financing costs		(61)	(399)
Repurchase of Common Shares to satisfy employee tax withholding	(4,214)	(2,481)	(1,424)
Tax benefits related to share-based compensation expense			977
Net cash (used for) provided by financing activities	(33,870)	40,785	(43,371)
Effect of exchange rate changes on cash and cash equivalents	(3,863)	4,561	(2,054)
Net change in cash and cash equivalents	15,089	15,614	(3,972)
Cash and cash equivalents at beginning of period	66,003	50,389	54,361
Cash and cash equivalents at end of period	81,092	66,003	50,389
Supplemental disclosure of cash flow information:
Cash paid for interest	4,997	5,746	5,786
Cash paid for income taxes, net	$ 13,213	$ 7,093	3,386
Supplemental disclosure of non-cash operating and financing activities:
Bank payment of vendor payables under short-term debt obligations			$ 3,764

The aggregate expense charged against earnings to allocate the cost of intangible assets including deferred financing costs (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. Also included in this amount is the accretion of the debt discount and the deferred financing costs which are a component of interest expense representing the periodic charge against earnings to reflect amortization of debt discounts and deferred financing costs over the life of the related debt instrument. As a noncash expense, this element is added back to net income when calculating cash provided by (used in) operations using the indirect method.

No definition available.